We exist to improve the lives
of everyone affected by epilepsy

Epilim Chronosphere MR (sodium valproate) 250mg granules out of stock in UK

23 Nov 2018

Update on 23 November 2018

This medicine is now back in stock.

Original story 30 October 2018

Epilim Chronosphere MR 250mg granules are temporarily out of stock. The maker of Epilim Chronosphere, Sanofi, expects to have them back in stock from 30 November 2018.

Other doses of Epilim Chronosphere are available. But Sanofi has advised pharmacists to avoid making up the dose with 50mg and 100mg granules. If they do, it’s likely these doses will also go out of stock.

If you are due to pick up a prescription for Epilim Chronosphere MR 250mg granules before 30 November, your pharmacist may need to give you a different version of your medicine. This might be a different manufacturer’s version of sodium valproate granules, or a different formulation of Epilim. Sanofi has written to healthcare professionals with advice on alternative options.

If you have any concerns about this, speak to your pharmacist, GP, epilepsy specialist or epilepsy specialist nurse.

Sanofi has told us the shortage is due to a temporary disruption in the production of valproate at their manufacturing site in France.

There are no comments yet. Be the first to comment...

Question about your epilepsy?

Your question will be sent to our helpline advisors.

Have a comment about this page?

All comments are reviewed by a moderator before publishing. Comments will be edited or deleted if they are offensive, libellous, slanderous, abusive, commercial or irrelevant.

We ask for your email when you make a comment through this website. This means that we can let you know directly that we have replied to you. By making a comment through the website, you allow us to use the comment in our publicity without using your name. If we would like to use your name, we will email you to get your permission.

The content of this field is kept private and will not be shown publicly.
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.